Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Medios acquires 74% stake in Caelo for EUR 9.4M

PRIVATEOct 18, 2026

Acquiring Company

Medios AG

Acquired Company

Caesar & Loretz GmbH

GermanyNorth Rhine WestphaliaManufacturingBiotechnologyPharmaceuticalManufacturingBiotechnologyPharmaceutical

Description

Medios AG completed the acquisition of 74.00 percent of Caesar & Loretz GmbH, known as Caelo, on October 1, 2026. This strategic move provides Medios with a German platform for active pharmaceutical ingredients. The transaction is valued at EUR 9.40 million, with expectations of generating EUR 40.00 million in revenue from Caelo. This acquisition aligns with Medios' growth strategy in the pharmaceutical market.

Company Information

Company

Medios AG

Location

Germany

About

Medios AG is a leading provider of specialty pharmaceuticals in Europe. The company focuses on optimizing operational efficiency, profitability, and cash conversion. Medios provides services that cater to the needs of pharmacies, hospitals, and industrial customers. It is involved in the acquisition and expansion of pharmaceutical supply chains throughout Europe.

Fundz sees it the moment Medios AG makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Thomas
Senior decision-maker at this company
••••••••@••••••••

See Thomas's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Medios AG's next move

Learn about Strategic plan

Frequently asked

Who acquired Caesar & Loretz GmbH?

Caesar & Loretz GmbH was acquired by Medios AG, based in Germany. The deal was reported on October 18, 2026. Medios AG is a leading provider of specialty pharmaceuticals in Europe. The company focuses on optimizing operational efficiency, profitability, and cash conversion. Medios AG is privately held and operates in Manufacturing.

When did Medios AG acquire Caesar & Loretz GmbH?

Medios AG's acquisition of Caesar & Loretz GmbH was reported on October 18, 2026. Medios AG completed the acquisition of 74.00 percent of Caesar & Loretz GmbH, known as Caelo, on October 1, 2026. This strategic move provides Medios with a German platform for active pharmaceutical ingredients. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Caesar & Loretz GmbH do?

Caesar & Loretz GmbH, known as Caelo, is a supplier of active pharmaceutical ingredients, excipients, and raw materials. It is privately held, operating in Manufacturing, and is based in North Rhine Westphalia.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.